Publications

5674 Results

SWOG S1216: A Phase III Randomized Trial Comparing Androgen Deprivation Therapy (ADT) + TAK-700 with ADT + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer (HSPC) (NCT01809691)

Authors
N Agarwal;C Tangen;M Hussain;P Lara;C Higano;D Vaena;G MacVicar;H Li;T Cirspino;DI Quinn;N Vogelzang;IM Thompson
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr TPS5102);ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), general poster session;
Year
2014
Research Committee(s)
Genitourinary
Study Number(s)
S1216

Meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 4,798 patients

Authors
P Blanchard;AMW Lee;J Leclercq;S Marquet;WT Ng;J Ma;ATC Chan;P Huang;G Zhu;DTT Chua;HQ Mai;J Wee;DLW Kwong;J Moon;KH Chi;G Fountzilas;M Hareyama;L Zhang;J Bourhis;J-P Pignon
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr 6022); ASCO (May 30-June 3, 2014, Chicago, IL), poster highlights session;
Year
2014
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

Gene expression signatures in pre- and post-therapy (Rx) specimens from CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer (BrCa)

Authors
LA Carey;WT Barry;B Pitcher;K Hoadley;MCU Cheang;IE Krop;NL Henry;DA Berry;CM Perou;EP Winer;CA Hudis
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr 506); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), oral session;
Year
2014
Research Committee(s)
Breast

CALGB/SWOG 80405: PHASE III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (uMCRC).

Authors
AP Venook;D Niedzwiecki;H-J Lenz;F Innocenti;MR Mahoney;BH O'Neil;JE Shaw;BN Polite;H Hochster;JN Atkins;RM Goldberg;RJ Mayer;RL Schilsky;M Bertagnolli;CD Blanke
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr LBA3); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), scientific plenary session (oral);
Year
2014
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

NCI pilot intervention program to assist accrual for challenging late phase clinical trials

Authors
A Denicoff;H Massett;E Souhan;JJ Welch;N Seibel;RF Little;BS Mann;K DiPiazza;M Rossmann;S Hartson Stine;R Lambersky;F Desanto;F Fonzi;D Schrag;RA Abrams;DJ Adelstein;PD Brown;M Mooney;J Abrams
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr 6617); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), general poster session;
Year
2014
Research Committee(s)
Leukemia
Study Number(s)
S1117

Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial

Authors
C Sweeney;H-Y Chen;MA Carducci;G Liu;D Jarrad;M Eisenberger;Y-N Wong;NM Hahn;M Kohli;N Vogelzang;MM Cooney;R Dreicer;J Picus;DH Shevrin;M Hussain;JA Garcia;RS DiPaola
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr LBA2); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), scientific plenary session (oral);
Year
2014
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/E3805

Randomized comparison of adjuvant treatment with aromatase inhibitor (AI) exemestane (E) plus ovarian function suppression (OFS) versus tamoxifen (T) plus OFS in premenopausal women with hormone receptor-positive (HR+) breast cancer (BC): joint analysis of TEXT and SOFT

Authors
O Pagani;M Ragan;G Fleming;M Colleoni;I Lang;C Tondini;H Burstein;E Perez;EM Ciruelos;V Stearns;E Bonnefoi;S Martino;M Rabaglio;AS Coates;RD Gelber;A Goldhirsch;P Francis;H Gomez
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr LBA1); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), LBA scientific plenary session (oral);
Year
2014
Research Committee(s)
Breast and Cancer Survivorship

Health-related quality of life outcomes in prostate cancer prevention clinical trials

Authors
C Moinpour
Journal / Conference
International Society for Quality of Life Research annual meeting (Berlin, Germany, Oct. 15-18, 2014); oral presentation;
Year
2014
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
Study Number(s)
S0000, SWOG-9217

Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results from the Prostate Cancer Prevention Trial

Authors
W Figg;C Chau;D Price;C Till;P Goodman;Y Cho;M Varella-Garcia;JK Reichardt;C Tangen;R Leach;A van Bokhoven;A Kristal;IM Thompson;MS Lucia
Journal / Conference
Urology 84(1):127-131;
Year
2014
Research Committee(s)
Cancer Control
PMID
PMID24824408
PMC
PMC4077907
Study Number(s)
SWOG-9217

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

Authors
BM Wolpin;C Rizzato;P Kraft;C Kooperberg;GM Petersen;Z Wang;AA Arslan;L Beane-Freeman;PM Bracci;J Buring;F Canzian;EJ Duell;S Gallinger;GG Giles;G Goodman;P Goodman;EJ Jacobs;A Kamineni;AP Klein;LN Kolonel;KH Kulke;D Li;N Malats;SH Olson;M Risch;HD Sesso;K Visvanathan;E White;W Zheng;CC Abnet;D Albanes;G Andriotti;M Austin;R Barfield;D Basso;SI Berndt;M-C Boutron-Ruault;M Brotzman;MW Buchler;H Bas Bueno-de-Mesquita;P Bugert;L Burdette;D Campa;G Capurso;C Chung;C Cotterchio;E Costello;J Elena;N Funel;JM Gaziano;N Giese;EL Giovannucci;M Goggins;MJ Gorman;M Gross;CA Haiman;M Hassan;K Helzlsouer;BE Henderson;EA Holly;N Hu;DJ Hunter;F Innocenti;M Jenab;R Kaaks;TJ Key;KT Khaw;EA Klein;M Kogevinas;J Kupcinskas;RC Kurtz;A LaCroix;MT Landi;S Landi;L Le Marchand;A Mambrini;S Mannisto;RL Milne;Y Nakamura;AL Oberg;K Owzar;S Panico;AV Patel;PHM Peeters;U Peters;A Piepoli;M Porta;FX Real;E Riboli;N Rothman;A Scarpa;XO Shu;DT Silverman;P Soucek;M Sund;R Talar-Wojnarowska;PR Taylor;GE Theodoropoulos;M Thornquist
Journal / Conference
Nature Genetics 46(9):994-1000;
Year
2014
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID25086665
PMC
PMC4191666
Study Number(s)
S0000